Compound 60 has a very superior affinity to MDM2 (Ki < 1 nM), powerful mobile action, and a very good oral pharmacokinetic profile. Compound sixty is able to achieving complete and very long-Long lasting tumor regression in vivo and it is at the moment in section I scientific trials for https://stewartq888nfx9.aboutyoublog.com/profile